Evidence map›Paper›PMID 20711449›Full record

ArticlePloS one2010

TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation.

Hailun Wang, Heping Yan, Allie Fu, Miaojun Han, Dennis Hallahan, Zhaozhong Han

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Blocking the functional domain of TIP1 by antibodies sensitizes cancer to radiation therapy.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Article
  3. Article
  4. PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  5. Article
  6. Review
  7. Tumor-targeting peptides from combinatorial libraries.Advanced drug delivery reviews · 2017
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. [Molecular diagnostics for monitoring and predicting therapeutic effect in cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2011
    Article
  19. Article
  20. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.Journal of controlled release : official journal of the Controlled Release Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hailun WangDepartment of Radiation Oncology, School of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.
Heping Yan
Allie Fu
Miaojun Han
Dennis Hallahan
Zhaozhong Han
Vanderbilt University · USWashington University in St. Louis · US

Funding

Vanderbilt In Vivo Cellular and Molecular Imaging CenterP50CA128323 · NCI · VANDERBILT UNIVERSITY · PI SHYR, YU · 2008 to 2012
$6.8M
FLK1 SINALING PROTECTS TUMOR VASCULATURE FROM RADIATIONR01CA089674 · NCI · VANDERBILT UNIVERSITY · PI HALLAHAN, DENNIS E · 2001 to 2008
$2.3M
X-ray Targeted Therapeutic Genes within NanoparticlesR01CA125757 · NCI · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2007 to 2011
$1.7M
Pharmacodynamic Assessment of RTK Inhibitors in CancerR01CA112385 · NCI · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2005 to 2009
$1.3M
Roles of TIP-1 in Cancer RadiotherapyR01CA127482 · NCI · VANDERBILT UNIVERSITY · PI HAN, ZHAOZHONG · 2008 to 2011
$1.1M
NCI NIH HHS P50 CA128323NCI NIH HHS R01 CA089674NCI NIH HHS R01 CA112385NCI NIH HHS R01CA112385NCI NIH HHS R01 CA125757NCI NIH HHS R01CA125757NCI NIH HHS R01 CA127482NCI NIH HHS R01CA127482NCI NIH HHS R01CA89674
6 · The paper itself

Abstract

backgroundTumor response to treatment has been generally assessed with anatomic and functional imaging. Recent development of in vivo molecular and cellular imaging showed promise in time-efficient assessment of the therapeutic efficacy of a prescribed regimen. Currently, the in vivo molecular imaging is limited with shortage of biomarkers and probes with sound biological relevance. We have previously shown in tumor-bearing mice that a hexapeptide (HVGGSSV) demonstrated potentials as a molecular imaging probe to distinguish the tumors responding to ionizing radiation (IR) and/or tyrosine kinase inhibitor treatment from those of non-responding tumors. METHODOLOGY/PRINCIPAL

findingsIn this study we have studied biological basis of the HVGGSSV peptide binding within the irradiated tumors by use of tumor-bearing mice and cultured cancer cells. The results indicated that Tax interacting protein 1 (TIP-1, also known as Tax1BP3) is a molecular target that enables the selective binding of the HVGGSSV peptide within irradiated xenograft tumors. Optical imaging and immunohistochemical staining indicated that a TIP-1 specific antibody demonstrated similar biodistribution as the peptide in tumor-bearing mice. The TIP-1 antibody blocked the peptide from binding within irradiated tumors. Studies on both of human and mouse lung cancer cells showed that the intracellular TIP-1 relocated to the plasma membrane surface within the first few hours after exposure to IR and before the onset of treatment associated apoptosis and cell death. TIP-1 relocation onto the cell surface is associated with the reduced proliferation and the enhanced susceptibility to the subsequent IR treatment. CONCLUSIONS/SIGNIFICANCE: This study by use of tumor-bearing mice and cultured cancer cells suggested that imaging of the radiation-inducible TIP-1 translocation onto the cancer cell surface may predict the tumor responsiveness to radiation in a time-efficient manner and thus tailor radiotherapy of cancer.

Indexed as

Amino Acid SequenceAnimalsAntibodiesAntibody SpecificityBinding, CompetitiveBiomarkersCarrier ProteinsCell Line, TumorCell MembraneCell ProliferationHumansIntracellular Signaling Peptides and ProteinsIntracellular SpaceMethyltransferasesMiceNeoplasmsAntibodiesBiomarkersCarrier ProteinsIntracellular Signaling Peptides and ProteinsMethyltransferasesOligopeptidesTAX1BP3 protein, humantension-induced inhibited protein, mouse

Identifiers

PMID20711449
PMCPMC2920312
OpenAlexW2155566007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.